This story is currently available in английский only — a translation isn't ready yet.
A clinical trial at Johns Hopkins University presents a new solution to tobacco addiction.
ℹ️ Озвучка браузером · студийный голос ИИ скоро

A clinical study conducted at Johns Hopkins University in the United States has shown that magic mushrooms may be effective in addressing smoking, one of the hardest addictions to quit. The scientific community is viewing this finding as a significant breakthrough.
Research participants who underwent psilocybin-based treatment achieved notable success rates in smoking cessation. The method offers a different approach from traditional nicotine replacement therapies. The findings will be published in relevant journals in the coming weeks.
In a clinical trial at Johns Hopkins University, psilocybin, a substance found in magic mushrooms, demonstrated success in smoking cessation at significantly higher rates than traditional methods such as nicotine patches. These findings point to a paradigm shift in addiction treatment.
A new treatment option may emerge for millions of people who smoke or are trying to quit, offering a more effective alternative to trial methods that have so far failed. At the same time, research into psilocybin for the treatment of depression and post-traumatic stress disorder indicates that new therapeutic options in mental health care may become accessible to patients in the near future.